As we discussed in the FY 2021 rulemaking, we recognize that the payer-specific negotiated charges negotiated between MAOs and hospitals may in some cases be based on a system other than MS-DRGs
[539] Further, we continue to believe, as indicated in the CY 2026 OPPS/ASC proposed rule that, for those hospitals that are assessed a CMP, the reduction of the CMP we are finalizing if the hospital elects not to appeal CMS' findings, would offset some of the hospital financial burden, including legal fees and costs associated with challenging the impositionincluding requesting and defending a hearing before an Administrative Law Judge (ALJ) and any subsequent appeals
In the world of medically guided weight loss, GLP-1 medications have gained attention for their ability to help individuals manage hunger, reduce body fat, and improve overall metabolic health
Ivim's approach lets your provider fine-tune your dose every week based on weight loss trajectory, side effects, and tolerance
Supplements that target appetite control and digestion must be evaluated not only for their potential benefits but also for their limitations, risks, and best-use practices